Overcoming Ovarian Cancer Chemoresistance
eBook - ePub

Overcoming Ovarian Cancer Chemoresistance

  1. 188 pages
  2. English
  3. ePUB (mobile friendly)
  4. Available on iOS & Android
eBook - ePub

Overcoming Ovarian Cancer Chemoresistance

Book details
Table of contents
Citations

About This Book

Overcoming Ovarian Cancer Chemoresistance presents non-overlapping review chapters that discuss the state of the field in overcoming chemoresistance of ovarian cancer and treatment options before and following recurrence, considering the genetic makeup of the ovarian cancer patient and her tumor. With the uptake of both germline and somatic gene testing, clinicians can obtain a more comprehensive understanding of ovarian tumors and this book provides information to link the genetic makeup of a tumor (or patient) with the best available treatment.

The book discusses topics such as strategies to fight chemo-resistance in ovarian cancer, circulating DNA as a monitor of response, BRCA mutations, ovarian cancer stem cells, immunotherapy and vaccines. Additionally, it brings a list of promising agents at clinical and pre-clinical stage that will impact the treatment in the near future.

This book is a valuable source for cancer researchers, oncologists and several members of biomedical field who need to understand how to battle chemoresistance in ovarian cancer.

  • Provides a comprehensive view of both biological and genetic determinants of resistance, as well as technical approaches to monitor response
  • Discusses genetic reversions as a unique alteration and a new field of study
  • Includes a chapter on upcoming and promising agents that are in the pre-clinical and early clinical space, to set the stage for future directions in the field

Frequently asked questions

Simply head over to the account section in settings and click on “Cancel Subscription” - it’s as simple as that. After you cancel, your membership will stay active for the remainder of the time you’ve paid for. Learn more here.
At the moment all of our mobile-responsive ePub books are available to download via the app. Most of our PDFs are also available to download and we're working on making the final remaining ones downloadable now. Learn more here.
Both plans give you full access to the library and all of Perlego’s features. The only differences are the price and subscription period: With the annual plan you’ll save around 30% compared to 12 months on the monthly plan.
We are an online textbook subscription service, where you can get access to an entire online library for less than the price of a single book per month. With over 1 million books across 1000+ topics, we’ve got you covered! Learn more here.
Look out for the read-aloud symbol on your next book to see if you can listen to it. The read-aloud tool reads text aloud for you, highlighting the text as it is being read. You can pause it, speed it up and slow it down. Learn more here.
Yes, you can access Overcoming Ovarian Cancer Chemoresistance by Goli Samimi,Christina Annunziata in PDF and/or ePUB format, as well as other popular books in Ciencias biológicas & Biología. We have over one million books available in our catalogue for you to explore.

Information

Year
2020
ISBN
9780128198414

Table of contents

  1. Cover image
  2. Title page
  3. Table of Contents
  4. Copyright
  5. Cover Image Insert
  6. Aims and Scope for Series “Cancer Sensitizing Agents for Chemotherapy”
  7. About the Series Editor
  8. Aims and Scope of Volume
  9. About the Volume Editors
  10. Preface
  11. Contributors
  12. Chapter 1: Epithelial ovarian cancer: Genomic landscape and evolving precision treatment
  13. Chapter 2: Overview of mechanisms of chemoresistance in ovarian cancer
  14. Chapter 3: The development of drug resistance through reversion mutation in BRCA genes in ovarian cancer
  15. Chapter 4: Ovarian cancer stem cell biology and chemoresistance
  16. Chapter 5: The use of immunotherapy for treatment of chemoresistant ovarian cancer
  17. Chapter 6: Models of ovarian cancer to test new agents
  18. Chapter 7: Novel agents to target treatment resistance in ovarian cancer
  19. Chapter 8: Promising agents on the horizon
  20. Index